238 related articles for article (PubMed ID: 10913401)
21. High levels of interleukin 10 and tumor necrosis factor alpha in cerebrospinal fluid during the onset of bacterial meningitis.
van Furth AM; Seijmonsbergen EM; Langermans JA; Groeneveld PH; de Bel CE; van Furth R
Clin Infect Dis; 1995 Jul; 21(1):220-2. PubMed ID: 7578738
[TBL] [Abstract][Full Text] [Related]
22. Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis.
Paul R; Lorenzl S; Koedel U; Sporer B; Vogel U; Frosch M; Pfister HW
Ann Neurol; 1998 Oct; 44(4):592-600. PubMed ID: 9778257
[TBL] [Abstract][Full Text] [Related]
23. Cerebrospinal fluid levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in subacute sclerosing panencephalitis.
Ichiyama T; Matsushige T; Siba P; Suarkia D; Takasu T; Miki K; Furukawa S
J Infect; 2008 May; 56(5):376-80. PubMed ID: 18395263
[TBL] [Abstract][Full Text] [Related]
24. Identification of a matrix-degrading phenotype in human tuberculosis in vitro and in vivo.
Price NM; Farrar J; Tran TT; Nguyen TH; Tran TH; Friedland JS
J Immunol; 2001 Mar; 166(6):4223-30. PubMed ID: 11238675
[TBL] [Abstract][Full Text] [Related]
25. Cefotaxime and ceftriaxone cerebrospinal fluid levels during treatment of bacterial meningitis in children.
Goldwater PN
Int J Antimicrob Agents; 2005 Nov; 26(5):408-11. PubMed ID: 16216469
[TBL] [Abstract][Full Text] [Related]
26. Serum matrix metalloproteinase-2 levels indicate blood-CSF barrier damage in patients with infectious meningitis.
Kanoh Y; Ohara T; Kanoh M; Akahoshi T
Inflammation; 2008 Apr; 31(2):99-104. PubMed ID: 18185989
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of an extended diagnostic PCR assay for detection and verification of the common causes of bacterial meningitis in CSF and other biological samples.
Bäckman A; Lantz P; Rådström P; Olcén P
Mol Cell Probes; 1999 Feb; 13(1):49-60. PubMed ID: 10024433
[TBL] [Abstract][Full Text] [Related]
28. Matrix metalloproteinase-9 (MMP-9) in human cerebrospinal fluid (CSF): elevated levels are primarily related to CSF cell count.
Yushchenko M; Weber F; Mäder M; Schöll U; Maliszewska M; Tumani H; Felgenhauer K; Beuche W
J Neuroimmunol; 2000 Oct; 110(1-2):244-51. PubMed ID: 11024556
[TBL] [Abstract][Full Text] [Related]
29. Scaling up of PCR-based surveillance of bacterial meningitis in the African meningitis belt: indisputable benefits of multiplex PCR assay in Niger.
Chanteau S; Sidikou F; Djibo S; Moussa A; Mindadou H; Boisier P
Trans R Soc Trop Med Hyg; 2006 Jul; 100(7):677-80. PubMed ID: 16359713
[TBL] [Abstract][Full Text] [Related]
30. Molecular studies of meningococcal and pneumococcal meningitis patients in Ethiopia.
Mihret W; Sletbakk Brusletto B; Øvstebø R; Siebke Troseid AM; Norheim G; Merid Y; Kassu A; Abebe W; Ayele S; Silamsaw Asres M; Yamuah L; Aseffa A; Petros B; Caugant DA; Brandtzaeg P
Innate Immun; 2019 Apr; 25(3):158-167. PubMed ID: 30894090
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the line probe assay for the rapid detection of bacterial meningitis pathogens in cerebrospinal fluid samples from children.
Soysal A; Toprak DG; Türkoğlu S; Bakir M
BMC Microbiol; 2017 Jan; 17(1):14. PubMed ID: 28077083
[TBL] [Abstract][Full Text] [Related]
32. MMPs contribute to TNF-alpha-induced alteration of the blood-cerebrospinal fluid barrier in vitro.
Zeni P; Doepker E; Schulze-Topphoff U; Huewel S; Tenenbaum T; Galla HJ
Am J Physiol Cell Physiol; 2007 Sep; 293(3):C855-64. PubMed ID: 17507431
[TBL] [Abstract][Full Text] [Related]
33. Tissue inhibitor of metalloproteinase 3, matrix metalloproteinase 9, and neopterin in the cerebrospinal fluid: preferential presence in HTLV type I-infected neurologic patients versus healthy virus carriers.
Lezin A; Buart S; Smadja D; Akaoka H; Bourdonné O; Perret-Liaudet A; Césaire R; Belin MF; Giraudon P
AIDS Res Hum Retroviruses; 2000 Jul; 16(10):965-72. PubMed ID: 10890358
[TBL] [Abstract][Full Text] [Related]
34. In bacterial meningitis cortical brain damage is associated with changes in parenchymal MMP-9/TIMP-1 ratio and increased collagen type IV degradation.
Sellner J; Leib SL
Neurobiol Dis; 2006 Mar; 21(3):647-56. PubMed ID: 16257222
[TBL] [Abstract][Full Text] [Related]
35. Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis.
Liuzzi GM; Trojano M; Fanelli M; Avolio C; Fasano A; Livrea P; Riccio P
Mult Scler; 2002 May; 8(3):222-8. PubMed ID: 12120694
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis.
Leib SL; Clements JM; Lindberg RL; Heimgartner C; Loeffler JM; Pfister LA; Täuber MG; Leppert D
Brain; 2001 Sep; 124(Pt 9):1734-42. PubMed ID: 11522576
[TBL] [Abstract][Full Text] [Related]
37. Elevated levels of MMP-9 and TIMP-1 in the cerebrospinal fluid of neuro-Behçet's disease.
Hamzaoui K; Maître B; Hamzaoui A
Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S52-7. PubMed ID: 19796534
[TBL] [Abstract][Full Text] [Related]
38. Blood-brain barrier damage in patients with bacterial meningitis: association with tumor necrosis factor-alpha but not interleukin-1 beta.
Sharief MK; Ciardi M; Thompson EJ
J Infect Dis; 1992 Aug; 166(2):350-8. PubMed ID: 1634806
[TBL] [Abstract][Full Text] [Related]
39. Elevation of matrix metalloproteinases 3 and 9 in cerebrospinal fluid and blood in patients with severe traumatic brain injury.
Grossetete M; Phelps J; Arko L; Yonas H; Rosenberg GA
Neurosurgery; 2009 Oct; 65(4):702-8. PubMed ID: 19834375
[TBL] [Abstract][Full Text] [Related]
40. Case-fatality ratio of bacterial meningitis in the African meningitis belt: we can do better.
Boisier P; Maïnassara HB; Sidikou F; Djibo S; Kairo KK; Chanteau S
Vaccine; 2007 Sep; 25 Suppl 1():A24-9. PubMed ID: 17521784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
